Learn / NRIX
NASDAQ: NRIX
Nurix Therapeutics (NRIX) stock, explained like you're 5
Nurix Therapeutics trades on the Nasdaq under the ticker NRIX. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.3 billion dollars.
- Ticker
- NRIX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 2.3 billion dollars
Is Nurix Therapeutics a small, medium or large cap company?
No. Nurix Therapeutics is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.3 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Nurix Therapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves NRIX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Nurix Therapeutics Insider Sold Shares Worth $528,528, According to a Recent SEC Filing (Yahoo Finance)
- Why Nurix Therapeutics Stock Is In Focus After A Profit Swing (Simply Wall Street)
- Nurix Therapeutics, Inc. (NRIX) Free Cash Flow 2025: $263.5M outflow, down 44.9% (Stock Titan)
- Nurix Therapeutics' (NRIX) Buy Rating Reaffirmed at Needham & Company LLC (MarketBeat)
- HC Wainwright & Co. maintains Buy rating on Nurix Therapeutics, $36 price target (TradingView)
Follow NRIX in your daily brief
Each trading day at 5 PM ET we post what happened to Nurix Therapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow NRIX
Questions about Nurix Therapeutics stock
What does Nurix Therapeutics do?
Nurix Therapeutics trades on the Nasdaq under the ticker NRIX. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 2.3 billion dollars.
What is the ticker symbol for Nurix Therapeutics?
Nurix Therapeutics trades under the ticker NRIX on the Nasdaq.
What is Nurix Therapeutics's market cap?
Nurix Therapeutics is a mid cap stock with a market cap of about 2.3 billion dollars.
How does Nurix Therapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves NRIX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow NRIX stock every day?
Add NRIX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.